Full Text View
Tabular View
No Study Results Posted
Related Studies
Intravenous Ancrod for the Treatment of Acute Ischemic Stroke Within 6 Hours After Onset of Symptoms
This study has been completed.
Study NCT00343174   Information provided by University of Heidelberg
First Received: June 20, 2006   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Brain Infarction
Cerebral Ischemia
Acute Stroke
Additional conditions recognized in this trial
Brain Ischemia
Cerebral Infarction
Infarction
Ischemia
Stroke
More general conditions related to this trial
Brain Diseases
Cardiovascular Diseases
Central Nervous System Diseases
Cerebrovascular Disorders
Necrosis
Nervous System Diseases
Pathologic Processes
Vascular Diseases
Interventions listed in this trial
Ancrod
More general drug interventions related to this trial
Anticoagulants
Cardiovascular Agents
Fibrin Modulating Agents
Fibrinolytic Agents
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
University of Heidelberg


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services